Gapping down
In reaction to disappointing earnings/guidance:
In reaction to disappointing earnings/guidance:
- ANW -25.7%, OOMA -15%, DY -14.4%, CHS -10.7%, TIF -5.5%, GOGL -3.7%, AAP -3.7%, LOW -3.4%
M&A news:
- BG -6.4% (issues statement regarding Glencore (GLNCY); not in discussions with Glencore)
Select metals/mining stocks trading lower - likely due to China exposure following Moody's downgrade:
- MT -1.4%, RIO -1.3%, BHP -0.9%, FCX -0.7%, CLF -0.7%
Select energy related names showing early weakness following PJM capacity auction results:
- DYN -3.7%, CPN -1.8%, EXC -0.5%
Other news:
- CVM -37.5% (provides update on clinical hold communications with the FDA regarding the previously announced partial clinical hold of CEL-SCI's Phase 3 clinical trial of its investigational drug Multikine in letter to shareholders)
- NBIX -8.5% (Neurocrine Biosci announces that the initial Phase II Tourette syndrome T-Force GREEN study of INGREZZA did not meet its primary endpoint)
- SNDX -6.6% ( to offer and sell $50 million of its common stock in an underwritten public offering)
- STNG -6.2% (Scorpio Tankers announces merger agreement with Navig8 Product Tankers and the launch of a concurrent public offering of common shares)
- UHS -4.9% (seeing continued weakness on reports of expanded probe)
- ALNY -3.3% (commences underwritten public offering of 5 mln shares of its common stock)
- TTD -1.3% (prices follow-on offering of 4,316,452 shares of common stock by selling stockholders at $52.00 per share)
Analyst comments:
- CIEN -3.2% (downgraded to Hold from Buy at Deutsche Bank)
- WHLR -1% (downgraded to Mkt Perform from Mkt Outperform at JMP Securities)
- ZION -0.6% (downgraded to Neutral from Buy at Goldman)